HLB Reapply for Liver Cancer Drug Approval from FDA
HLB logo. On 16 May this year, the FDA issued a Complete Response Letter (CRL) requesting...
HLB logo. On 16 May this year, the FDA issued a Complete Response Letter (CRL) requesting...
Progression-free survival (PFS) in intermediate-stage hepatocellular carcinoma (HCC) improved by almost 5 months when a targeted agent and immunotherapy were...
Following abdominal surgery in 2024, surgeons removed some tissue from Catherine’s abdomen, which was later tested and found to be...
Dublin, Sept. 11, 2024 (GLOBE NEWSWIRE) -- The "India Liver Cancer Therapeutics Market, By Region, Competition, Forecast & Opportunities, 2020-2030F"...
Surgical oncologists at MD Anderson Cancer Center at Cooper in Camden used histotripsy, an innovative noninvasive technology that uses sound...
Hong Kong billionaire Li Ka-shing participated in the donation of a liver cancer treatment device to the Faculty of Medicine...